Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
aflibercept (zaltrap) (1 trial)
citicoline (1 trial)
docosahexaenoic acid (1 trial)
vitamin c (1 trial)
Macular Degeneration (Phase 4)
Wet Macular Degeneration (Phase 4)
Trials (2 total)
Trial APIs (4 total)